NCT02129751View on ClinicalTrials.gov

Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

246

Participants

Timeline

Start Date

June 30, 2026

Primary Completion Date

July 31, 2029

Study Completion Date

December 31, 2029

Conditions

Major Depressive Disorder

Interventions

DRUG

bupropion hydrobromide

study drug

DRUG

Placebo

placebo arm

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY